Docmode Health Technologies LimitedDHTLCorporate

E-Learning Latest results: Mar 2026 7 quarters of data
₹22.30
MCap ₹7 Cr
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹8 Cr
Sales · Mar 2026
-64.1% YoY
₹-1 Cr
Operating Profit · Mar 2026
-102.8% YoY
-15.1%
OPM % · Mar 2026
-459.3% YoY
₹-0 Cr
Net Profit · Mar 2026
+95.6% YoY
₹-0.21
EPS · Mar 2026
+95.6% YoY

📝 Docmode Health Technologies Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Docmode Health Technologies Limited reported revenue of ₹8 crore for the quarter ended March 2026 (Q4 FY26), down 64.1% from ₹21 crore in the same quarter last year.

The company reported a net loss of ₹0 crore, against a net loss of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.21.

Operating profit stood at ₹-1 crore — an operating margin (OPM) of -15.1%, compared with -2.7% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹26 crore with a net loss of ₹0 crore.

Valuation snapshot

At the current price of ₹22.30, DHTL has a market capitalisation of ₹7 crore.

Within the E-Learning industry, it is the 4th-largest of the 5 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 29.50%, public shareholders 70.50% of Docmode Health Technologies Limited.

Promoter holding slipped from 30.86% to 29.50% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹7 Cr
Current Price ?
₹22.3
P/E ?
N/A
Industry P/E ?
N/A
P/B ?
0.85
P/S ?
0.27
P/FCF ?
N/A
Enterprise Value ?
₹11 Cr
EV/EBITDA ?
-30.18
PEG ?
N/A
Earnings Yield ?
-5.5%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹26 Cr
OPM ?
-1.4%
Profit after tax (TTM) ?
₹-0 Cr
EPS (TTM) ?
₹-0.50
ROCE ?
-0.3%
ROE ?
-1.9%
ROA ?
-0.5%
Growth
Sales — latest qtr ?
₹8 Cr
PAT — latest qtr ?
₹-0 Cr
YoY qtr sales growth ?
-64.1%
YoY qtr profit growth ?
95.6%
Sales growth (3y) ?
50%
Sales growth (5y) ?
43%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹4 Cr
Debt to Equity ?
0.45
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
29.50%
Change in promoter holding ?
-17.94%
Pledged percentage ?
N/A
Market
Return 3 months ?
-40.5%
Return 6 months ?
-44.2%

🗓️ Quarterly results (7 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026 YoY % QoQ %
Sales 2024162021188 -64.1% —
Operating Profit 13-1-0-11-1 -102.8% —
Other Income 0001001 +1372.0% —
Interest 1111110 -86.1% —
Depreciation 0000000 -24.2% —
Profit Before Tax 12-2-1-1-0-0 +95.5% —
Net Profit 11-1-1-2-0-0 +95.6% —
EPS 2.665.93-3.72-1.65-4.80-0.29-0.21 +95.6% —
OPM % 7.2% 11.5% -5.1% -0.6% -2.7% 4.5% -15.1% -459.3% —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 5 periods)

Metric Mar 2023Mar 2024Mar 2025Sep 2025Mar 2026 % Chg
Equity Capital 2.293.143.143.143 +0.0%
Reserves 1.197.245.215.125 -0.8%
Borrowings 8.489.186.827.454 -49.9%
Other Liabilities 5.0510.6224.1422.2922 -3.3%
Total Liabilities 17.0130.1839.3138.0033 -11.8%
Fixed Assets 0.050.971.2214.071 -93.0%
CWIP 2.038.5011.600.0013 —
Investments 1.201.261.291.301 +0.8%
Other Assets 13.7319.4525.2022.6318 -21.7%
Total Assets 17.0130.1839.3138.0033 -11.8%

💧 Cash Flow (latest 5 periods)

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -2.05-0.834.496.644 -34.5%
Cash from Investing Activity -1.52-1.57-7.55-3.67-2 +48.5%
Cash from Financing Activity 3.412.655.76-4.27-4 +4.9%
Net Cash Flow -0.170.252.70-1.30-2 -23.8%
Free Cash Flow -2.42-2.43-2.932.99— —
CFO/OP -103%-22%238%-981%— —

➗ Ratios (latest 4 periods)

Metric Mar 2022Mar 2023Mar 2024Mar 2025 % Chg
Debtor Days 112.2692.03104.8580.86 -22.9%
Inventory Days 588.71——— —
Days Payable 379.13——— —
Cash Conversion Cycle 321.8492.03104.8580.86 -22.9%
Working Capital Days 92.2850.0711.06-54.26 -590.6%
ROCE % 48.71%42.00%12.69%-0.35% -102.8%

👥 Shareholding (latest 4 periods)

Metric Dec 2024Mar 2025Sep 2025Mar 2026 % Chg
Promoters 47.44%47.44%30.86%29.50% -4.4%
Public 52.56%52.56%69.14%70.50% +2.0%
No. of Shareholders 262246221195 -11.8%

⚖️ Peer comparison

Industry: E-Learning · 5 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VERANDA Veranda Learning ₹231.80 2,237 43.6 429 61 31.3% 14.1% 1.9% 113.1% 7.4% 467.9%
2 JARO Jaro Institute ₹473.70 1,055 — — — — — — — — —
3 517063 Jetking Infotrain ₹57.41 79 — 21 -3 -21.4% -14.4% 2.0% -123.7% -12.8% -267.5%
4 DHTL Docmode Health ₹104.70 33 — 26 -0 -1.4% -0.6% — — -64.1% 94.9%
5 GTECJAINX G-TEC JAINX ₹26.45 27 — 7 -1 -9.3% -9.7% -0.1% 74.3% -10.6% 98.6%
❓ Frequently asked questions
What was Docmode Health Technologies Limited's revenue in Q4 FY26?
Docmode Health Technologies Limited reported revenue of ₹8 crore for the quarter ended March 2026 (Q4 FY26), down 64.1% from ₹21 crore in the same quarter last year.
What was Docmode Health Technologies Limited's net profit in Q4 FY26?
The company reported a net loss of ₹0 crore, against a net loss of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.21.
What is DHTL's market capitalisation and P/E ratio?
At the current price of ₹22.30, DHTL has a market capitalisation of ₹7 crore.
Who owns Docmode Health Technologies Limited? (shareholding pattern)
As of Mar 2026, promoters held 29.50%, public shareholders 70.50% of Docmode Health Technologies Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI